NORCROSS, Ga., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the scientific ...
NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) shares were down more than 6% at last check Wednesday. The Boston-based company announced preclinical data for its novel “G-Protein-Coupled Receptor 119 ...
(Reuters) -Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene therapy after a participant developed serious liver injury, the company said ...
A six-year-old boy was left with a ruptured liver after a woman flied off a slide at a water park and crashed into him. CCTV footage shows the child's father ignoring warnings from staff and swimming ...